Biofrontera Inc. — Director's Dealing 2022

Jan 20, 2022

SEC Form 4/A — Form 4/A

Issuer: Biofrontera Inc. (BFRI)
CIK: 0001858685
Period of Report: 2021-12-09

Reporting Person: Gates Erica F. (Controller)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-12-09	Employee stock option (right to buy)	$4.77	A	20408	Acquired	2031-12-09	Common Stock (20408)	Direct

Footnotes

F1: The reporting person's Form 4 filed with the SEC on December 13, 2021 inadvertently reported an incorrect exercise price with respect to the Employee stock option (right to buy).

F2: The option vests in three equal annual installments beginning on December 9, 2022.